A new, powerful Citizen Portal experience is ready. Switch now

Panel advances bill to require medical examiners to review recent vaccinations in unexplained infant deaths

March 25, 2026 | 2026 Legislature Arizona, Arizona


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Panel advances bill to require medical examiners to review recent vaccinations in unexplained infant deaths
Senator Schamp, sponsor of SB 10‑11, described the bill as a narrowly targeted reform to strengthen investigations of sudden and unexplained infant deaths by ensuring medical examiners review immunization and countermeasure history in the 90 days before a death. “Families deserve answers,” the sponsor said, framing the measure as improving data collection rather than assigning blame.

Supporters argued better standardized data can help identify public‑health risks and prevention opportunities. Representative Fink and others noted this aligns with CDC‑recommended practices and could create more timely state‑level data to act on trends more quickly than waiting on federal compilations.

Opponents warned the bill may duplicate existing processes. Ashley Chambers, director of Arizona Families for Vaccines, testified that the state’s child‑fatality review process already includes a four‑page checklist that covers vaccinations and medications for infant deaths, and cautioned that a state database could show correlations (high vaccination rates among most infants) that do not imply causation. Ruthie Goldcorn, an obstetrics/pediatrics practitioner, said SIDS is typically linked to unsafe sleep practices and that expanding investigatory requirements could retraumatize grieving families without preventing deaths.

Sponsor Schamp said the bill is a “simple data collection bill” and pledged efforts to maintain sensitivity to families while collecting standardized information to identify possible preventable causes.

The committee returned SB 10‑11 with a due‑pass recommendation (reported 4 ayes, 3 nays). The sponsor and witnesses agreed to continue discussions about how the data are collected and protected.

Outcome and next step: SB 10‑11 was reported out of committee with a due‑pass recommendation and will go to the full House for consideration.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee